Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension
- PMID: 3128465
- PMCID: PMC1433609
- DOI: 10.1136/gut.29.3.372
Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension
Abstract
We have evaluated the haemodynamic effects of intravenous (iv) nitroglycerin (NG) and vasopressin (VP) alone and in combination, in 12 patients with cirrhosis and recent variceal haemorrhage (two to seven days). Nitroglycerin infusion alone (200 micrograms/min) produced a significant fall in portal pressure (WHVP-FHVP) (from 16.4 (0.6) to 13.3 (1.2) mmHg; p less than .001) associated with hypotension (mean arterial pressure from 95 (7) to 78 (9) mmHg; p less than 0.005). Vasopressin alone (0.4 IU/min) reduced portal pressure (20.7 (1.3) to 14.0 (1.3) mmHg; p less than 0.001), but there was considerable variation in the systemic haemodynamic changes with increased cardiac output in four of six patients. The combination of vasopressin and nitroglycerin corrected all systemic haemodynamic disturbances produced by either agent alone. This combination led, however, to a further reduction in portal pressure (from 13.7 (0.9) to 11.7 (0.7) mmHg p less than 0.01). These results show that: (1) intravenous nitroglycerin reduces portal pressure, and (2) the combination of nitroglycerin and vasopressin reverses systemic haemodynamic disturbances produced by either agent alone and leads to a further decrease in portal pressure.
Similar articles
-
The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.Drugs. 1990 Jan;39(1):38-53. doi: 10.2165/00003495-199039010-00004. Drugs. 1990. PMID: 2178911 Review.
-
Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.Am J Gastroenterol. 1992 Jun;87(6):719-24. Am J Gastroenterol. 1992. PMID: 1590307
-
Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.J Hepatol. 1990 May;10(3):370-4. doi: 10.1016/0168-8278(90)90149-l. J Hepatol. 1990. PMID: 2114437
-
Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.J Hepatol. 1989 May;8(3):308-15. doi: 10.1016/0168-8278(89)90028-7. J Hepatol. 1989. PMID: 2499616
-
[Pharmacological therapy of portal hypertension].Schweiz Med Wochenschr. 1985 Oct 19;115(42):1468-75. Schweiz Med Wochenschr. 1985. PMID: 2866582 Review. German.
Cited by
-
Acute management of bleeding oesophageal varices.Drugs. 1992;44 Suppl 2:14-23; discussion 70-2. doi: 10.2165/00003495-199200442-00004. Drugs. 1992. PMID: 1385067 Review.
-
The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.Drugs. 1990 Jan;39(1):38-53. doi: 10.2165/00003495-199039010-00004. Drugs. 1990. PMID: 2178911 Review.
-
Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.Dig Dis Sci. 1997 Mar;42(3):529-35. doi: 10.1023/a:1012993224326. Dig Dis Sci. 1997. PMID: 9073134 Clinical Trial.
-
The management of an episode of variceal bleeding.Postgrad Med J. 1991 Feb;67(784):140-6. doi: 10.1136/pgmj.67.784.140. Postgrad Med J. 1991. PMID: 2041843 Free PMC article. Review. No abstract available.
-
Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.J Gastroenterol. 1994 Aug;29(4):460-8. doi: 10.1007/BF02361244. J Gastroenterol. 1994. PMID: 7951857
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources